Literature DB >> 6177932

Hypotensive action of commercial intravenous amiodarone and polysorbate 80 in dogs.

W B Gough, R H Zeiler, P Barreca, N El-Sherif.   

Abstract

Commercial intravenous amiodarone has been reported to have antiarrhythmic actions and to cause only mild hypotension in humans. In the dog, however, amiodarone was observed to cause severe hypotension. Since commercial intravenous amiodarone is amiodarone compound (50 mg/ml) dissolved in water with polysorbate 80 (Tween 80) (100 mg/kg), the effects of amiodarone in ethanol (5 mg/kg) and polysorbate 80 (10 mg/kg) were studied individually, and in combination in anesthetized dogs. Commercial intravenous amiodarone and polysorbate 80 caused at least a 60% drop in mean blood pressure and left ventricular maximum dP/dt for at least 30 min, whereas amiodarone in ethanol did not. The drop in blood pressure was not principally due to peripheral vasodilation. Therefore, in dogs the diluent polysorbate 80 is the major cause of severe hypotension resulting from commercial intravenous amiodarone. These studies show that commercial intravenous amiodarone produces results different in dogs than has been previously reported in humans. Therefore: (a) canine models for studying the antiarrhythmic actions of commercial intravenous amiodarone would produce results complicated by severe hypotension; and (b) polysorbate 80 is not an inert substance, but is a potent cardiac depressant.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6177932     DOI: 10.1097/00005344-198205000-00006

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  15 in total

1.  Administration of substances to laboratory animals: routes of administration and factors to consider.

Authors:  Patricia V Turner; Thea Brabb; Cynthia Pekow; Mary Ann Vasbinder
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-09       Impact factor: 1.232

Review 2.  Comparative hemodynamics of antiarrhythmic drugs.

Authors:  M Sami
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

3.  Acute amiodarone toxicity due to an administration error: could excipient be responsible?

Authors:  Silvana Masi; Stéphan Clément de Cléty; Christine Anslot; Thierry Detaille
Journal:  Br J Clin Pharmacol       Date:  2009-06       Impact factor: 4.335

4.  Amiodarone. Biochemical aspects and haemodynamic effects.

Authors:  J P Gagnol; C Devos; M Clinet; P Nokin
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

Review 5.  Amiodarone in long term prophylaxis.

Authors:  D Katritsis; A J Camm
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 6.  Practical aspects of the use of amiodarone.

Authors:  P Puech
Journal:  Drugs       Date:  1991       Impact factor: 9.546

7.  Alterations to the electrical activity of atrial muscle isolated from the rat heart, produced by exposure in vitro to amiodarone.

Authors:  B J Northover
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

8.  The effect of amiodarone pretreatment on survival of mice with cocaine toxicity.

Authors:  Christopher R DeWitt; Nathan Cleveland; Richard C Dart; Kennon Heard
Journal:  J Med Toxicol       Date:  2005-12

9.  Histamine-releasing properties of Polysorbate 80 in vitro and in vivo: correlation with its hypotensive action in the dog.

Authors:  E Masini; J Planchenault; F Pezziardi; P Gautier; J P Gagnol
Journal:  Agents Actions       Date:  1985-09

10.  Effects of polysorbates and Cremophor EL on vascular responses in rat aorta.

Authors:  H Zengil; U Hodoğlugil; Z Güney
Journal:  Experientia       Date:  1995-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.